|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5698671A
(en)
|
1989-03-21 |
1997-12-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Metalloproteinase peptides
|
|
JP3156082B2
(ja)
*
|
1989-03-21 |
2001-04-16 |
アメリカ合衆国 |
マトリックスメタロプロテイナーゼ阻害剤ペプチド
|
|
US6797492B2
(en)
|
1991-05-17 |
2004-09-28 |
Merck & Co., Inc. |
Method for reducing the immunogenicity of antibody variable domains
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
JP3017591B2
(ja)
|
1992-01-17 |
2000-03-13 |
富士薬品工業株式会社 |
抗ヒトtimp−2モノクローナル抗体の製法およびその利用
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6391265B1
(en)
|
1996-08-26 |
2002-05-21 |
Biosite Diagnostics, Inc. |
Devices incorporating filters for filtering fluid samples
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
US6045899A
(en)
|
1996-12-12 |
2000-04-04 |
Usf Filtration & Separations Group, Inc. |
Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
|
|
DE69837544T2
(de)
|
1997-07-16 |
2007-12-20 |
Charm Sciences, Inc., Lawrence |
Testgerät und methode zur entdeckung von analyten in proben
|
|
JP2002507725A
(ja)
|
1998-03-16 |
2002-03-12 |
クイデル コーポレイション |
イムノアッセイデバイスおよび方法
|
|
US7214542B2
(en)
|
2003-01-30 |
2007-05-08 |
Michael Hutchinson |
Method of processing assay test results
|
|
WO2004096832A2
(en)
|
2003-04-29 |
2004-11-11 |
Children's Medical Center Corporation |
Novel antiangiogenic peptides
|
|
US20070031286A1
(en)
|
2003-08-11 |
2007-02-08 |
Kyowa Medex Co., Ltd. |
Tool for measuring object to be measured, measuring device, and measuring method
|
|
EP1774338B1
(en)
|
2004-07-28 |
2009-06-03 |
F.Hoffmann-La Roche Ag |
Timp-2 as target/marker of beta cell failure
|
|
US7485468B2
(en)
|
2004-10-15 |
2009-02-03 |
Galapagos Bv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
|
|
WO2007048100A2
(en)
|
2005-10-18 |
2007-04-26 |
The Government Of The United States, As Represented By The Secretary Of Health & Human Services |
Angio-inhibitory peptides derived from human timp-2
|
|
WO2010048346A1
(en)
|
2008-10-21 |
2010-04-29 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US8900881B2
(en)
|
2008-12-30 |
2014-12-02 |
Jin Po Lee |
Quantitative analyte assay device and method
|
|
EP3150635A3
(en)
|
2009-10-16 |
2017-06-21 |
Omeros Corporation |
Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
|
|
MX342967B
(es)
|
2009-12-20 |
2016-10-19 |
Astute Medical Inc |
Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
|
|
CN102791885B
(zh)
|
2010-02-05 |
2015-09-09 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
WO2011125877A1
(ja)
|
2010-03-31 |
2011-10-13 |
積水メディカル株式会社 |
イムノクロマトグラフィーを利用した測定方法、イムノクロマトグラフィー用テストストリップ及びイムノクロマトグラフィー用測定試薬キット
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
CA2810825A1
(en)
|
2010-09-30 |
2012-04-05 |
Yoshiro Niitsu |
Modulation of timp1 and timp2 expression
|
|
CA2846602A1
(en)
|
2011-08-26 |
2013-03-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP3540440B1
(en)
|
2011-12-08 |
2022-09-28 |
Astute Medical, Inc. |
Methods and uses for evaluating renal injury and renal status
|
|
WO2013158274A1
(en)
|
2012-04-20 |
2013-10-24 |
Academia Sinica |
ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
|
|
WO2014031476A1
(en)
|
2012-08-21 |
2014-02-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
|
JP6681195B2
(ja)
|
2013-01-17 |
2020-04-15 |
アスチュート メディカル,インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
|
WO2014197729A1
(en)
|
2013-06-05 |
2014-12-11 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR20160039682A
(ko)
*
|
2013-08-07 |
2016-04-11 |
아스튜트 메디컬 인코포레이티드 |
생물학적 샘플에서 개선된 성능을 가지는 timp2에 대한 검정
|
|
AU2014346695B2
(en)
|
2013-11-06 |
2020-10-15 |
Astute Medical, Inc. |
Assays for IGFBP7 having improved performance in biological samples
|
|
CN110007084B
(zh)
|
2013-12-03 |
2022-11-18 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
|
KR101605421B1
(ko)
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
|
GB201505314D0
(en)
|
2015-03-27 |
2015-05-13 |
Victrex Mfg Ltd |
Polymeric materials
|
|
WO2016164854A1
(en)
|
2015-04-09 |
2016-10-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
AU2017277305A1
(en)
|
2016-06-06 |
2018-12-20 |
Astute Medical, Inc. |
Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
|
|
EP3532101B1
(en)
|
2016-10-28 |
2021-12-08 |
Astute Medical, Inc. |
Use of antibodies to timp-2 for the improvement of renal function
|
|
CN110431422A
(zh)
|
2017-02-06 |
2019-11-08 |
机敏医药股份有限公司 |
用于肾损伤和肾衰竭的诊断和预后的方法和组合物
|
|
WO2018187453A1
(en)
|
2017-04-05 |
2018-10-11 |
Astute Medical, Inc. |
Assays for timp2 having improved performance in biological samples
|
|
WO2018208684A1
(en)
|
2017-05-07 |
2018-11-15 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|